x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Weekly Dose of GenAI Adoption

Welcome to the "Accelerating GenAI Adoption Podcast" hosted by Indy Sawhney. Weekly AI-hosted discussions explore GenAI insights, use cases, and research based on Indy"s LinkedIn newsletters. Experience newsletter content as dynamic audio conversations to enhance your understanding of generative AI technologies. Tune in for thought-provoking dialogues that empower you to navigate the evolving GenAI landscape. Music credits: I Miss You, Southern Winds by | e s c p |

technology

All Episodes

00:05:14

Weekly Dose of GenAI Adoption - Episode 85

Weekly Dose of GenAI Adoption ·

2025/11/22

The provided text comes from the "Weekly Dose of GenAI Adoption" newsletter, edition #85, authored by Indy Sawhney, a Generative AI Strategy & Adoption Leader at AWS. The central focus is on practical, actionable insights for accelerating the adoption of Generative AI (GenAI) within the enterprise, particularly in the healthcare and life sciences sector. A significant portion of the newsletter details a specific experiment within a big pharma company where an "agentic AI" was

en

00:04:36

Weekly Dose of GenAI Adoption - Episode 84

Weekly Dose of GenAI Adoption ·

2025/11/15

The source material is the 84th edition of the "Weekly Dose of GenAI Adoption" newsletter, authored by Indy Sawhney, a Generative AI Strategy & Adoption Leader at AWS who focuses on the healthcare and life sciences industry. The newsletter provides an overview of why 95% of enterprise GenAI pilots fail, citing MIT research that found this failure is due to organizations misunderstanding how to integrate AI. Specifically, the research shows that human-AI combinations underperform on

en

00:06:48

Weekly Dose of GenAI Adoption - Episode 83

Weekly Dose of GenAI Adoption ·

2025/11/08

The sources consist of excerpts from the "Weekly Dose of GenAI Adoption newsletter," authored by Indy Sawhney, a Generative AI Strategy & Adoption Leader at AWS, who focuses on the healthcare and life sciences industry. The primary theme of the newsletter is that GenAI serves as an amplification tool, not a replacement for human expertise and deep domain knowledge, using the Boeing 787 Dreamliner’s outsourcing failures as an extended metaphor for the risks of relying too heavily on

en

00:05:01

Weekly Dose of GenAI Adoption - Episode 82

Weekly Dose of GenAI Adoption ·

2025/11/01

The sources provide an overview of the challenges and best practices for adopting agentic AI in enterprise settings, focusing on the gap between vendor hype and operational reality. Authored by Indy Sawhney, a Generative AI Strategy & Adoption Leader at AWS, the text emphasizes that successful AI integration must be a phased business transformation, not a risky "big bang" IT rollout, drawing a parallel to Western Digital's successful consolidation strategy. Key concerns preventing

en

00:05:06

Weekly Doze of GenAI Adoption - Episode 81

Weekly Dose of GenAI Adoption ·

2025/10/25

The sources, excerpts from the "Weekly Dose of GenAI Adoption" newsletter by Indy Sawhney, focus on how Generative AI (GenAI) can transform healthcare by restoring empathy and humanity amidst systemic crises. Sawhney, a Generative AI Strategy and Adoption Leader at AWS, argues that the most impactful near-term application of GenAI is not complex automation, but rather scaling personalized, compassionate care to patients who are currently underserved due to clinician burnout and staff

en

00:05:55

Weekly Dose of GenAI Adoption - Episode 80

Weekly Dose of GenAI Adoption ·

2025/10/18

The source material, primarily excerpts from the "Weekly Dose of GenAI Adoption" newsletter, edition #80, focuses on a strategic approach for implementing Generative AI (GenAI) in enterprise settings. Written by Indy Sawhney, a Generative AI Strategy & Adoption Leader at AWS, the newsletter advocates for adopting the Kaizen philosophy of continuous, small improvements—a concept borrowed from Toyota—instead of attempting large-scale, "big bang" deployments. The core advice

en

00:06:36

Weekly Dose of GenAI Adoption - Episode 79

Weekly Dose of GenAI Adoption ·

2025/10/11

The source consists of excerpts from the Weekly Dose of GenAI Adoption newsletter, authored by Indy Sawhney, a Generative AI Strategy and Adoption Leader at AWS who specializes in healthcare and life sciences. The primary focus is on accelerating GenAI adoption, particularly through Low-Code/No-Code (LCNC) agentic platforms that empower business users to redesign core workflows. These platforms are presented as a modern echo of a 1984 Canon "user innovation" experiment, shifting the power

en

00:05:47

Weekly Dose of GenAI Adoption - Episode 78

Weekly Dose of GenAI Adoption ·

2025/10/04

The sources consist of excerpts from the Weekly Dose of GenAI Adoption newsletter, edition 78, written by Indy Sawhney, a Generative AI Strategy & Adoption Leader at AWS who advises the biopharma and biotech sectors. This newsletter focuses on providing enterprise leaders with actionable insights for accelerating the adoption of Generative AI (GenAI). The central theme is the rapidly widening AI maturity divide between organizations, emphasizing that successful adoption requires organizational

en

00:05:23

Weekly Dose of GenAI Adoption - Episode 77

Weekly Dose of GenAI Adoption ·

2025/09/27

The source material, an excerpt from the "Weekly Dose of GenAI Adoption" newsletter written by Indy Sawhney, cautions enterprise leaders against viewing the adoption of agentic AI as a simple purchase, or an "Add to cart" solution. Sawhney, a Generative AI Strategy & Adoption Leader at AWS, explains that agentic AI is a complex, autonomous system that requires robust systems engineering, including orchestration, observability, compliance, and rigorous cost control. The author

en

00:05:24

Weekly Dose of GenAI Adoption - Episode 76

Weekly Dose of GenAI Adoption ·

2025/09/20

The source material, an excerpt from the "Weekly Dose of GenAI Adoption" newsletter by Indy Sawhney, discusses the challenges and strategies for accelerating the adoption of Agentic AI within the healthcare industry. It emphasizes that achieving the Healthcare Quadruple Aim—better patient experience, population health, lower costs, and care team well-being—requires more than just technology; it demands a convergence of leadership alignment, updated regulations, and cross-industry

en

00:05:18

Weekly Dose of GenAI Adoption - Episode 75

Weekly Dose of GenAI Adoption ·

2025/09/13

This newsletter, authored by Indy Sawhney, a Generative AI Strategy & Adoption Leader at AWS, focuses on practical approaches for enterprises to achieve significant ROI with GenAI. It highlights that while most GenAI pilots fail to demonstrate return on investment, successful implementations leverage "Agentic AI" to reengineer core workflows, rather than simply adding new tools. The source draws a parallel to Wall Street's "straight-through processing" (STP) as a

en

00:09:53

Weekly Dose of GenAI Adoption - Episode 74

Weekly Dose of GenAI Adoption ·

2025/09/06

Welcome to Episode 74 of the "Weekly Dose of GenAI Adoption" podcast! This episode dives deep into AI governance in the era of Agentic AI, where machines increasingly take autonomous actions, blurring the lines of responsibility. Join Indy Sawhney, a Generative AI Strategy & Adoption Leader at AWS, as he explains why effective AI governance is fundamentally a human and leadership challenge, not merely a technical one. He emphasizes that for enterprises to truly thrive, accountability

en

00:05:00

Weekly Dose of GenAI Adoption - Episode 73

Weekly Dose of GenAI Adoption ·

2025/08/30

Weekly Dose of GenAI Adoption newsletter by Indy Sawhney, discusses strategies for enterprises to successfully implement Generative AI (GenAI). The central theme of this episode highlights that only a small percentage of companies are realizing value from GenAI, largely because they focus on low-risk, internal back-office operations rather than highly visible, complex, or customer-facing applications. Indy emphasizes that starting with tasks like document preparation or financial reporting allows

en

00:06:27

Weekly Dose of GenAI Adoption - Episode 72

Weekly Dose of GenAI Adoption ·

2025/08/23

Welcome to the 72nd edition of the "Weekly Dose of GenAI Adoption newsletter" written by Indy Sawhney, a Generative AI Strategy & Adoption Leader at AWS. The newsletter focuses on accelerating GenAI adoption in enterprises, particularly within the healthcare and life sciences industries, although its insights are presented as broadly applicable. A central theme is the lack of ROI in many GenAI pilots, a problem the author likens to past struggles with cloud and ERP implementations due to

en

00:06:08

Weekly Dose of GenAI Adoption - Episode 71

Weekly Dose of GenAI Adoption ·

2025/08/16

The "Weekly Dose of GenAI Adoption" newsletter, specifically its 71st edition, champions a strategic approach to accelerating Generative AI (GenAI) adoption within enterprises. The author, Indy Sawhney from AWS, argues against relying solely on external vendors, instead advocating for the internal mobilization of "forward-deployed" engineering teams. These small, cross-functional units, inspired by Amazon's "2-Pizza Team" model, are positioned close to business problems, enabling rapid, iterative

en

00:10:05

Weekly Dose of GenAI Adoption - Episode 70

Weekly Dose of GenAI Adoption ·

2025/08/09

This podcast consists of excerpts from the "Weekly Dose of GenAI Adoption newsletter" authored by Indy Sawhney, a Generative AI Strategy & Adoption Leader at AWS. The central theme is that companies should not create a separate GenAI strategy, but instead integrate GenAI as a tool to accelerate their existing business objectives, such as enhancing revenue, efficiency, quality, and innovation. Sawhney emphasizes that GenAI's true value emerges when it directly contributes to

en

00:05:50

Weekly Dose of GenAI Adoption - Episode 69

Weekly Dose of GenAI Adoption ·

2025/08/02

The "Weekly Dose of GenAI Adoption newsletter" by Indy Sawhney, an expert in Generative AI strategy at AWS. The 69th edition, primarily addresses the perceived barrier of compliance in the healthcare and life sciences (HCLS) industry concerning GenAI adoption. Sawhney argues that compliance often serves as an excuse for institutional fear and resistance to change, rather than a true impediment, highlighting that even the FDA is embracing GenAI. The author encourages leaders to view

en

00:13:32

Weekly Dose of GenAI Adoption - Episode 68

Weekly Dose of GenAI Adoption ·

2025/07/26

This newsletter focuses on accelerating GenAI adoption within enterprises, particularly in healthcare and life sciences. The author, Indy Sawhney from AWS, argues that "cost" is frequently a convenient excuse for delaying GenAI implementation, masking deeper issues like discomfort with change, misaligned ownership, or lack of organizational readiness. Drawing parallels to historical technology shifts like EHR and cloud adoption, the newsletter provides actionable advice for leaders to identify and

en

00:10:06

Weekly Dose of GenAI Adoption - Episode 67

Weekly Dose of GenAI Adoption ·

2025/07/19

The "Weekly Dose of GenAI Adoption" newsletter, authored by Indy Sawhney, a Generative AI Strategy & Adoption Leader at AWS, addresses the common challenges enterprises face when integrating GenAI. Sawhney identifies four primary barriers: the myth of "no value", emphasizing the difficulty in proving value at scale; "value but no alignment", highlighting how fragmented priorities stall projects; the misconception of "too expensive", often masking

en

00:05:36

Weekly Dose of genAI Adoption - Episode 66

Weekly Dose of GenAI Adoption ·

2025/07/12

The 66th edition of the "Weekly Dose of GenAI Adoption" newsletter by Indy Sawhney, a Generative AI Strategy & Adoption Leader at AWS, offers practical insights for enterprise leaders on accelerating GenAI adoption, particularly within healthcare and life sciences. The newsletter highlights that GenAI adoption is a nonlinear process, often experiencing a "mid-cycle dip" in enthusiasm before significant value is realized. It emphasizes that cultural hurdles, such as "AI

en

105 results

Similar Podcasts

Lead With AI

Tamara Nall

Linux in the Ham Shack

Black Sparrow Media

Data Engineering Podcast

Tobias Macey

Eye On A.I.

Craig S. Smith

Reflections

Livewire Labs